ARTICLE | Product Development

Biopharmas must address the reality of racial disparities in health outcomes exposed by COVID-19

COVID-19 shows why biopharmas need to build racial equity into their drug development mindset

September 8, 2020 11:04 PM UTC

This is the second article in BioCentury’s 28th Annual Back to School package. In the opening piece, BioCentury called on biopharma to convert its COVID response to a new era of efficient drug development and address the urgent healthcare chasms exposed by the crisis.

2020 has rung the alarm bell for biopharmas to address racial disparities in health outcomes.  ...